|1|Identification of a Subset of Human Non-Small Cell Lung Cancer Patients with High PI3KI^ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma. (24284056)
Cumberbatch M.... Womack C.
|2|Squamous Cell Carcinoma of the Lung with Metastasis to the GI Tract Associated with EGFR Exon 19 Deletion. (24171005)
Weiss G.J.... Kukunoor R.N.
|3|Bone marrow-derived cells contribute to NDEA-induced lung squamous cell carcinoma. (23055190)
Luo D.... Liu G.
|4|Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung. (24244672)
Holzer T.R.... Nasir A.
|5|Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung. (24128713)
Brunner A.M.... Hammerman P.S.
|6|Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents. (22984810)
Cagle P.T.... Low P.S.
|7|Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma. (24240590)
Hanada S.... Wanibuchi H.
|8|Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype. (23081722)
Ono S.... Ochiai A.
|9|The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma. (23906871)
Han X.... Zhang W.
|10|The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma. (23801129)
Hayashi A.... Takahashi K.
|11|Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. (22006338)
Wang N.J.... Cho R.J.
|12|ALK translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers. (21847065)
Klempner S.J.... Costa D.B.
|13|Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma. (21168900)
Kunert-Keil C.... Gedrange T.
|14|A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. (21890451)
Tan X.... He J.
|15|The expression of PEBP4 protein in lung squamous cell carcinoma. (21887552)
Yu G.P.... Ji Y.
|16|Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. (20643781)
Wilkerson M.D.... Hayes D.N.
|17|Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. (19176476)
Poschmann G.... StA1hler K.
|18|Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. (19273703)
Lebanony D.... Mansukhani M.
|19|Epidermal growth factor receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung. (19543508)
Park S.H.... Lee J.H.
|20|Metastatic potential of lung squamous cell carcinoma associated with HSPC300 through its interaction with WAVE2. (19576655)
Cai X.... Zhang K.
|21|Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. (18676750)
Skrzypski M.... Rosell R.
|22|Minimal deletion regions in lung squamous cell carcinoma: association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers. (17931740)
Tseng R.C.... Wang Y.C.
|23|Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. (18364444)
Zhang H.... Xiao X.
|24|Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. (17585317)
Paschoud S.... Citi S.
|25|Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component. (17238183)
Ohtsuka K.... Watanabe T.
|26|Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. (16644410)
Bruylant K.... De Deyn P.P.
|27|COX-2 expression during early lung squamous cell carcinoma oncogenesis. (16055866)
Mascaux C.... Sculier J.P.
|28|Expression of PKB protein in human squamous-cell carcinoma and adenocarcinoma of lung]. (15946565)
Liao Y.D.... Fu X.N.
|29|Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. (16006773)
Kato Y.... Osawa M.
|30|Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. (16022908)
Bartling B.... Simm A.
|31|Squamous cell carcinoma of the lung producing granulocyte colony-stimulating factor and resembling a malignant pleural mesothelioma. (15005252)
Kobashi Y.... Sakamoto K.
|32|Stevens-Johnson syndrome induced by paclitaxel in a patient with squamous cell carcinoma of the lung: a case report. (15154637)
Hiraki A.... Takeyama H.
|33|Paraneoplastic cerebellar degeneration (PCD) associated with squamous cell carcinoma of the lung. (15335190)
Konishi J.... Nishimura M.
|34|Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. (15246564)
Sun W.... Gao Y.
|35|Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types. (12711114)
Gao W.M.... Keohavong P.
|36|Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. (12397651)
Lu W.... Lin D.
|37|High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients. (11054023)
MiAcdougAc M.... Serre G.
|38|Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. (11277326)
Tas F.... Saip P.
|39|Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma. (10857885)
Sun S.S.... Kao C.H.
|40|Pulmonary alveolar proteinosis with lung squamous cell carcinoma. (10464867)
Kadota J.... Kohno S.
|41|Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients. (10507778)
Werle B.... Spiess E.
|42|Increased NM23: MTS1 ratio inversely correlated with metastasis behaviour in human lung squamous cell carcinoma. (9066685)
Hsu J.W.... Chiang C.D.
|43|Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. (7718322)
Fontanini G.... Bevilacqua G.
|44|DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. (8302602)
Sachse R.... Sekiya T.
|45|Establishment of a human lung squamous cell carcinoma cell line LK-17, and characterization of procoagulant, platelet aggregation and metastatic potential]. (8297820)
Mori N.... Yasutomi M.
|46|Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits. (1330347)
Volm M.... Mattern J.
|47|Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. (1683776)
Tateishi M.... Sugimachi K.
|48|Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. (2311066)
Body J.J.... Bureau G.
|49|Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung. (6327315)
Joss R.A.... Rozencweig M.
|50|Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. (77725)
Mintz U.... Golomb H.M.